Avadel Pharmaceuticals plc
Major Drugs - Chesterfield, MO, US
Avadel Pharmaceuticals plc Employees
Danielle Burroughs
Senior Director, Medical Affairs Operations & Risk Management
Avadel Pharmaceuticals plc Senior Management
Avadel Pharmaceuticals plc Details
Avadel (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Our current lead drug candidate, FT218, is an investigational formulation of sodium oxybate leveraging our proprietary drug delivery technology and designed to be taken once at bedtime for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy.At Avadel, our core values foster an atmosphere of innovation and collaboration. In everything we do, we consider the patient experience, listening to their needs as we pursue the development and delivery of medicines that will transform the treatment landscape and have the greatest impact on people living with narcolepsy.Learn more about us at www.avadel.com and follow us on Twitter at @AvadelPharma.
Avadel Pharmaceuticals plc Technologies
Email Providers
Outlook
Content Delivery Networks
Amazon CloudFront
Domain Name Services
Route 53
Email Delivery
Mailchimp Mandrill
Other
Microsoft Office 365
Hosting
Amazon AWS